Catalyst

Slingshot members are tracking this event:

Genfit NASH program targeting Nonalcoholic Steatohepatitis with biomarkers plans to begin development in the second half of 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
GNFTF Community voting in process
GNFT.PA Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 23, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Nonalcoholic Steatohepatitis, Biomarkers, Nash